INTERNATIONAL PATENT: MYRICX PHARMA LIMITED FILES APPLICATION FOR "ANTIBODY DRUG CONJUGATE COMPRISING NMT INHIBITOR CONJUGATED TO AN ANTIBODY"

GENEVA, Sept. 16 -- MYRICX PHARMA LIMITED (125 Wood StreetLondon EC2V 7AW) filed a patent application (PCT/EP2025/056308) for "ANTIBODY DRUG CONJUGATE COMPRISING NMT INHIBITOR CONJUGATED TO AN ANTIBODY" on Mar 07, 2025. With publication no. WO/2025/186448, the details related to the patent application was published on Sep 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZAMMARCHI, Francesca (c/o MyricX Pharma Limited125 Wood StreetLondon EC2V 7AW), TOBIN, Jonathan (c/o MyricX Pharma Limited125 Wood StreetLondon EC2V 7AW), SOLARI, Roberto (c/o MyricX Pharma Limited125 Wood StreetLondon EC2...